The interaction mechanism of plasma iron transport protein transferrin with nanoparticles.

Transferrin / chemistry Protein Corona / chemistry Nanoparticles / chemistry Iron / metabolism Protein Binding
Functions Interaction Nanoparticles Transferrin iron release

Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
15 Jun 2023
Historique:
received: 27 11 2022
revised: 21 03 2023
accepted: 10 04 2023
medline: 26 5 2023
pubmed: 16 4 2023
entrez: 15 4 2023
Statut: ppublish

Résumé

In the biological systems, exposure to nanoparticles (NPs) can cause complicated interactions with proteins, the formation of protein corona and structural changes to proteins. These changes depend not only on NP physicochemical properties, but also on the intrinsic stability of protein molecules. Although, the formation of protein corona on the surface of NPs and the underlying mechanisms have been fully explored in various studies, no comprehensive review has discussed the direct biochemical and biophysical interactions between NPs and blood proteins, particularly transferrin. In this review, we first discussed the interaction of NPs with proteins to comprehend the effects of physicochemical properties of NPs on protein structure. We then overviewed the transferrin structure and its direct interaction with NPs to explore transferrin stability and its iron ion (Fe

Identifiants

DOI: 10.1016/j.ijbiomac.2023.124441 PMID: 37060978
pubmed: 37060978
pii: S0141-8130(23)01335-1
doi: 10.1016/j.ijbiomac.2023.124441
pii:
doi:

Substances chimiques

Transferrin 0
Protein Corona 0
Iron E1UOL152H7

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

124441

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no conflicts of interest.

Auteurs

Suliman Khan (S)

Medical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China; Department of Medical Lab Technology, The University of Haripur, Pakistan.

William C Cho (WC)

Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong.

Arif Hussain (A)

School of Life Sciences, Manipal Academy of Higher Education, Dubai, United Arab Emirates.

Sadaf Azimi (S)

Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Mohammad Mahdi Nejadi Babadaei (MMN)

Department of Molecular Genetics, Faculty of Biological Science, North Tehran Branch, Islamic Azad University, Tehran, Iran.

Samir Haj Bloukh (SH)

Department of Clinical Sciences, College of Pharmacy and Health Sciences, Ajman University, PO Box 346, Ajman, United Arab Emirates; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.

Zehra Edis (Z)

Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, PO Box 346, Ajman, United Arab Emirates.

Mesha Saeed (M)

Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands.

Timo L M Ten Hagen (TLM)

Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands; Nanomedicine Innovation Center Erasmus (NICE), Erasmus MC, Rotterdam, the Netherlands.

Hosein Ahmadi (H)

Department of Molecular Medicine, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.

Mahsa Ale-Ebrahim (M)

Department of Physiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Laila Abdulmohsen Jaragh-Alhadad (LA)

Department of Chemistry, College of Science, Kuwait University, Safat 13060, Kuwait. Electronic address: laila.alhadad@ku.edu.kw.

Rizwan Hasan Khan (RH)

Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, UP 202002, India. Electronic address: rhkhan.cb@amu.ac.in.

Mojtaba Falahati (M)

Precision Medicine in Oncology (PrMiO), Department of Pathology, Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands; Nanomedicine Innovation Center Erasmus (NICE), Erasmus MC, Rotterdam, the Netherlands. Electronic address: m.falahati@erasmusmc.nl.

Xiaoju Zhang (X)

Department of Respiratory and Clinical Care Medicine, Henan Provisional People's Hospital, Zhengzhou, China. Electronic address: zhangxiaoju@zzu.edu.cn.

Qian Bai (Q)

Medical Research Center, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Electronic address: baiqian@zzu.edu.cn.

Articles similaires

Conservation of the cooling agent binding pocket within the TRPM subfamily.

Kate Huffer, Matthew C S Denley, Elisabeth V Oskoui et al.
1.00
TRPM Cation Channels Animals Binding Sites Mice Pyrimidinones

Drug repurposing against fucosyltransferase-2 via docking, STD-NMR, and molecular dynamic simulation studies.

Muhammad Atif, Humaira Zafar, Atia-Tul- Wahab et al.
1.00
Fucosyltransferases Drug Repositioning Molecular Docking Simulation Molecular Dynamics Simulation Humans

Magnitude and factors associated with iron supplementation among pregnant women in anemia hot spot regions of Ethiopia: Multilevel analysis based on Bayesian approach.

Yilkal Negesse, Habtamu Temesgen, Wubetu Woyraw et al.
1.00
Humans Female Ethiopia Pregnancy Adult

Reprogramming cellular senescence in the tumor microenvironment augments cancer immunotherapy through multifunctional nanocrystals.

Zheng Wang, Yinglu Chen, Hui Fang et al.
1.00
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals

Classifications MeSH

questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Métalloprotéines › Protéines de liaison au fer › Transferrines › Transferrine › The interaction mechanism of plasma iron...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Couronne de protéines › The interaction mechanism of plasma iron...
questionsmedicales.fr › Technologie, industrie et agriculture › Produits manufacturés › Nanostructures › Nanoparticules › The interaction mechanism of plasma iron...
questionsmedicales.fr › Produits chimiques inorganiques › Métaux › Métaux lourds › Fer › The interaction mechanism of plasma iron...
questionsmedicales.fr › Métabolisme › Liaison aux protéines › The interaction mechanism of plasma iron...